Clinical Trials Directory

Trials / Completed

CompletedNCT04223297

Blue Protocol Assessment

Interest Assessment of the Blue Protocol in Improving Diagnosis of Dyspneic Patients in Pre- and Intra-hospital Emergency Medicine

Status
Completed
Phase
Study type
Observational
Enrollment
115 (actual)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Acute dyspnea is a common disease in emergency medicine. Mortality remains high is estimated at 15%. One third of initial diagnoses before paraclinical examination are estimated to be inaccurate. Lung ultrasound is a quick and immediate examination. Also, it is provided and performed at the bedside. The " Blue protocol " was designed by Daniel A. Lichtenstein as a diagnostic aid in dyspneic patients. It allows to obtain a diagnostic in more than 90% of acute dyspnea. However there is no validation in emergency medicine. The main purpose is to evaluate the interest of the " Blue protocol "in the management and orientation of the dyspneic patient

Conditions

Interventions

TypeNameDescription
PROCEDURElung ultrasoundThe lung ultrasound will be performed by following the " Blue protocol "

Timeline

Start date
2020-01-01
Primary completion
2020-09-01
Completion
2020-09-01
First posted
2020-01-10
Last updated
2023-01-18

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04223297. Inclusion in this directory is not an endorsement.